Hessam

Pharm. D. Clinical Pharmacist

[Azita Talasaz, PharmD @AzitaTalasaz]

So thrilled to see this 2-year effort finally in print on the first day of Spring! Sincerely appreciate @bbikdeli dedicated support! Incredibly grateful to have the chance of learning from a multidisciplinary team of amazing colleagues and exemplary mentors! @NatRevCardiol

[Hessam @hessamkkvnd]

@AzitaTalasaz @psadeghipour @Ortega_Paz @Maryamkouchak @beaverspharmd @johnfanikos @accpcardprn I’m proud of being a part of this great effort. It was not possible without your tremendous support. Thanks for involving me.

[Hessam @hessamkkvnd]

@Arsenwenpen 🥹

[Hessam @hessamkkvnd]

@AzitaTalasaz Wow 🤩
Totally deserved it 👌🏼
Kudos 🎉🍾🎈

[Hessam @hessamkkvnd]

Another nail in the coffin of pentoxifylline⚰️
Based on our latest RCT (#PENTOS), led by @AzitaTalasaz pre-procedural IV #pentoxifylline did not improve angiographic outcomes (TIMI, cTFC, MBG) in patients with STEMI undergoing PCI
#ACC2023
@Maryamkouchak

https://t.co/Yp684MX7J1

[Mohammad Saadatagah @smsaadatagah]

Presenting the result of our study #PENTOS trial where we studied the benefit of #pentoxifyllin in #STEMI led by @AzitaTalasaz at #ACC2023.
@BCMDeptMedicine @BCMHeart @BCM_CVRI
Please find the paper https://t.co/At8IaOrVXz

[Hessam @hessamkkvnd]

Endlessly thankful for your professional and kind guidance @VCUDPOSChair @virani_md @bvantassell
And I will also treasure the insights you’ve given us through your mentorship @AzitaTalasaz

[Journal of Cardiovascular Pharmacology @JCVPOnline]

What benefit does colchicine offer in STEMI patients prior to PPCI?

https://t.co/Ttm2zbaKCU

#coronary #infarct #echocardiography #inflammation #pharmacy #treatment #medicine #clinicaltrial #thrombus #troponin #prevention

[Hessam @hessamkkvnd]

@Arsenwenpen خیلی دیر کشف کردی حاجی 😂

[JACC Journals @JACCJournals]

This #JACC state-of-the-art review summarizes the ongoing or completed RCTs of lipid-modulating agents in #COVID19 and the implications of these trials for patient management. https://t.co/6nD5aROMhT #CardioTwitter

[Behnood Bikdeli @bbikdeli]

In @JACCJournals, we summarize why #statins, #omega3 fatty acids, #fibrates, and others may be of interest for #prevention or #treatment of #COVID19, discussing 40 #RCTs, even for #LongCOVID. Led by @AzitaTalasaz @brighamresearch @harvardmed @crfheart

https://t.co/CaBUNUsSeU

[Behnood Bikdeli @bbikdeli]

Ongoing #RCTs of novel #antithrombotic agents for #COVID-19. Great work by @AzitaTalasaz. Grateful for the support & guidance from @psadeghipour @connors_md @bhwords @PlateletDoc @bvantassell @MiddeldorpS @IsthPresident @MaryCushmanMD 🙏🙏 In @JTHjournal: https://t.co/UjqyohEP9M

[Azita Talasaz, PharmD @AzitaTalasaz]

Glad to see this review in print @JCVPOnline, grateful to @jccoondog for his dedicated support, thankful to my hard-working diligent team @hessamkkvnd @Maryamkouchak

[Azita Talasaz, PharmD @AzitaTalasaz]

Happy to see this paper finally in print @JACCPJournal with special thanks to the great team of authors, amazing experience with @bbikdeli best mentors and colleagues @psadeghipour @bvantassell @hessamkkvnd @Maryamkouchak

[Azita Talasaz, PharmD @AzitaTalasaz]

Thrilled to see this review article finally in pre-print!
So excited to be a part of this great team, with my sincere appreciation to @bbikdeli, @psadeghipour @bvantassell ,team of experienced investigators and my hardworking colleagues @hessamkkvnd @Maryamkouchak @Elahe95630676

[Journal of Cardiovascular Pharmacology @JCVPOnline]

In case you missed it.
Here is one of the JCVP articles with an outstanding engagement rate (11.2%) on Twitter in 2020.

[Hessam @hessamkkvnd]

Great work 🤩
Congrats to everyone 🥳
@AzitaTalasaz @psadeghipour @bvantassell @CardiacRX @Maryamkouchak

[Azita Talasaz, PharmD @AzitaTalasaz]

Congratulations to my honorable co-authors for this fantastic manuscript on Pharmacotherapy perspectives of COVID-19 Cardiovascular Complications! @hessamkkvnd @bvantassell @psadeghipour @CardiacRX